Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- 52-wk high
- $50.88
- 52-wk low
- $32.48
- Prev close
- $41.19
- Mkt cap
- $45.62B
- P/E
- 42.9x
- Fwd P/E
- 23.0x
Smart money
Earnings
Earnings came in 56.7% above what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $6.89B | $7.79B | $7.35B | $7.68B |
| Cost of what it sold | $5.16B | $5.87B | $5.69B | $5.47B |
| Gross profit | $1.73B | $1.91B | $1.67B | $2.21B |
| What it spent | ||||
| Sales and admin | — | $1.26B | $1.23B | $1.29B |
| Other operating costs | $1.10B | $224.0M | $15.0M | $525.0M |
| Total operating expenses | $1.10B | $1.49B | $1.24B | $1.82B |
| What was left | ||||
| Operating profit | $629.0M | $425.0M | $422.0M | $395.0M |
| Interest on debt | $233.0M | $166.0M | $165.0M | $168.0M |
| Profit before tax | $359.0M | $206.0M | $291.0M | $235.0M |
| Tax | $26.0M | $26.0M | $52.0M | $96.0M |
| Net profit | $333.0M | $180.0M | $129.0M | $60.0M |
| EBITDA | $842.0M | $382.0M | $681.0M | $659.0M |
Technicals
Price structure
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
Coverage is bearish
Tone of tracked coverage
GIC-tied Medline Inc. (MDLN) sells 1.6M shares at $35.80 in August 2026
BearishAug 17MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the Firm
BearishAug 13Kaplan Fox is Investigating Medline Inc. (NASDAQ: MDLN) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm
Leans bearish